June 30, 2008

New guidelines on the management of blastomycosis include several new therapies developed since the 2000 edition was published....Read Full Article

The European Union has approved its first pre-pandemic vaccine, targeted against H5N1 influenza. The question now becomes, in the absence of a pandemic, how widely should these vaccines be used? ...Read Full Article

In this new feature, a panel of IDSA members identifies and critiques important new infectious diseases studies in the current literature that have a significant impact on the practice of infectious diseases medicine....Read Full Article

Summaries of selected research published in the May issues of The Journal of Infectious Diseases and Clinical Infectious Diseases. ...Read Full Article

Recent messages from IDSA's FDA and CDC alert services....Read Full Article

An EIN member’s patient had not developed an immune response after two complete series of hepatitis B vaccine. The member asked for advice on additional measures to generate seroconversion, including the possibility of intradermal administration. The following is a sampling of the responses....Read Full Article

The clinical trials NIAID has requested closely reflect recommendations IDSA made to the institute last summer....Read Full Article

IDSA’s Clinical Affairs Committee has developed a new resource to help members and their billing staffs choose the appropriate level of evaluation and management (E&M) service code....Read Full Article

As Medicare prepares to stop reimbursing hospitals for certain hospital acquired conditions, IDSA and SHEA continue to advocate a cautious approach that protects patient safety without resulting in unintended consequences....Read Full Article

The Food and Drug Administration (FDA) has proposed a streamlined process for updating breakpoints of antibacterials, a move intended to help correct outdated information that clinicians rely on to predict what therapies are likely to be successful for treating infections....Read Full Article